Clinical Trials Browser

Has results × Skin Neoplasms × Vemurafenib × Clear all

NCT01909453 2026-02-27

COLUMBUS

Phase 3 Completed

921 enrolled 48 charts 1 FDA

Melanoma, Neoplasm Metastasis, Neoplasms, Skin Diseases, Skin Neoplasms

NCT01474551 2015-11-18

Vemurafenib (R05185426) in Poor Performance Status Patients With Unresectable Locally Advanced or Metastatic Melanoma Harboring a V600E/K Mutation

Phase 2 Terminated

2 enrolled 6 charts

Melanoma, Skin Neoplasms